Effect of ziprasidone dose on rates of medication discontinuation in acute schizophrenia or schizoaffective disorder

被引：0
|
作者：
Karayal, O.
Citrome, L. [2 ]
Yang, R. [1 ]
Harnett, J. [3 ]
Glue, P. [4 ]
机构：
[1] Pfizer Inc, Statistics, New York, NY USA
[2] Nathan S Kline Inst Psychiat Res, New York, NY USA
[3] Pfizer Inc, Global Outcomes, New York, NY USA
[4] Pfizer Inc, Clin Sci Grp, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：160 / 160
页数：1
相关论文
共 50 条
  • [41] Efficacy of ziprasidone in the treatment of schizoaffective disorder: An analysis of 2 fixed dose, placebo-controlled trials
    Warrington, L.
    Loebel, A.
    Lombardo, I.
    Yang, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S278 - S278
  • [42] Association between previous high-dose antipsychotic therapy and brexpiprazole discontinuation after the initiation of brexpiprazole in patients with schizophrenia or schizoaffective disorder
    Yoshimura, Yusaku
    Shimizu, Hiroma
    Yamashita, Rieko
    Washida, Kenji
    Takeda, Toshihiko
    Aoki, Shozo
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2020, 35 (02) : 98 - 104
  • [43] Efficacy of ziprasidone in the treatment of schizoaffective disorder: An analysis of two fixed dose, placebo-controlled trials
    Warrington, Lewis
    Lombardo, Ilise
    Loebel, Antony
    Rappard, Fred
    Yang, Ruoyong
    BIPOLAR DISORDERS, 2006, 8 : 36 - 37
  • [44] Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: Results of a multi-centre observational trial
    Kudla, Duerten
    Lambert, Martin
    Domin, Sabine
    Kasper, Siegfried
    Naber, Dieter
    EUROPEAN PSYCHIATRY, 2007, 22 (03) : 195 - 202
  • [45] Acute electroconvulsive therapy in the elderly with schizophrenia and schizoaffective disorder: A case series
    Kumagaya, David Yoshihito
    ASIA-PACIFIC PSYCHIATRY, 2019, 11 (04)
  • [46] Acute electroconvulsive therapy in the elderly with schizophrenia and schizoaffective disorder: a literature review
    Kumagaya, David
    Halliday, Graeme
    AUSTRALASIAN PSYCHIATRY, 2019, 27 (05) : 472 - 476
  • [47] A DOUBLE-BLIND COMPARISON OF THE SAFETY AND EFFICACY OF LURASIDONE AND ZIPRASIDONE IN CLINICALLY STABLE OUTPATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER
    Cucchiaro, Josephine
    Potkin, S. G.
    Ogasa, M.
    Loebel, A.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 342 - 343
  • [48] Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
    Potkin, Steven G.
    Ogasa, Masaaki
    Cucchiaro, Josephine
    Loebel, Antony
    SCHIZOPHRENIA RESEARCH, 2011, 132 (2-3) : 101 - 107
  • [49] Metabolic screening in primary care for patients with schizophrenia or schizoaffective disorder and taking antipsychotic medication
    Keenan, Rawiri
    Chepulis, Lynne
    Ly, Joanna
    Carter, Sally
    Lao, Chunhuan
    Asim, Muhammad
    Bhat, Abhijit
    Deo, Shivam
    Lim, Kee Ping
    Mohammed, Ruzaimah
    Scarlet, Sophie
    Lawrenson, Ross
    JOURNAL OF PRIMARY HEALTH CARE, 2020, 12 (01) : 29 - 34
  • [50] A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder
    Babatope, Taiwo
    Chotalia, Jigar
    Elkhatib, Rania
    Mohite, Satyajit
    Shah, Joel
    Goddu, Sumana
    Patel, Ruchir Arvind
    Aimienwanu, Osarhiemen Ruth
    Patel, Devanshu
    Makanjuola, Titilayo
    Okusaga, Olaoluwa O.
    PSYCHIATRIC QUARTERLY, 2016, 87 (04) : 729 - 737
12345